unmodified synthetic somatostatin , given as a 200-microgram intravenous bolus , plus 200 microgram infused over 3 hours , had no effect on basal plasma insulin and pancreatic glucagon-like immunoreactivity ( gli ) levels , both in controls and in patients with chronic pancreatitis .
C0030274
pancreatic
C0149521
chronic pancreatitis